Ginkgo Bioworks Holdings, Inc. (DNA) shareholders
Close on Nov 17, 2026Market cap $560.27MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Jason Kelly | 85,752,333 | 5.00% | 13D (active) amendment | Feb 14, 2024 |
| Barry Canton Joint filing with Reshma P. Shetty (9.50%) | 4,716,084 | 9.50% | 13D (active) amendment | Feb 14, 2025 |
| BlackRock, Inc. | 4,122,510 | 7.70% | 13G (passive) amendment | Jun 30, 2026 |
| Cascade Investment, L.L.C. Joint filing with William H. Gates III (7.50%) | 3,621,636 | 7.50% | 13G (passive) amendment | Sep 30, 2025 |
| Viking Global Opportunities Parent GP LLC Joint filing with Viking Global Investors LP (7.10%), Viking Global Opportunities GP LLC (7.10%) and 4 more | 3,577,128 | 7.10% | 13G (passive) amendment | Mar 31, 2026 |
| Austin Che | 2,372,573 | 5.00% | 13G (passive) amendment | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of DNA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,282,903 | 6.36% | $42.44M | +640,556 | 0.00% |
| Viking Global Investors LP | 3,577,128 | 5.31% | $35.45M | – | 0.10% |
| Erste Asset Management GmbH | 2,536,939 | 3.77% | $25.90M | +589,211 | 0.20% |
| Baillie Gifford & Co | 2,391,649 | 3.55% | $23.70M | – | 0.02% |
| Vanguard Capital Management LLC | 2,087,293 | 3.10% | $20.69M | +172,865 | 0.00% |
| Anchorage Capital Group, L.L.C. | 1,746,363 | 2.59% | $17.31M | – | 3.84% |
| Legal & General Group Plc | 1,669,419 | 2.48% | $16.54M | +7,832 | 0.00% |
| State Street Corp | 1,472,370 | 2.19% | $14.59M | +125,711 | 0.00% |
| Geode Capital Management, LLC | 1,222,016 | 1.81% | $12.11M | +212,654 | 0.00% |
| Forbes J M & Co Llp | 999,911 | 1.48% | $9.91M | −28,480 | 0.78% |
| Vanguard Portfolio Management LLC | 937,803 | 1.39% | $9.29M | +372,151 | 0.00% |
| Allianz Asset Management GmbH | 785,798 | 1.17% | $7.79M | +85,282 | 0.01% |
| UBS Group AG | 691,659 | 1.03% | $6.85M | +108,860 | 0.00% |
| Millennium Management LLC | 638,676 | 0.95% | $6.33M | +150,719 | 0.00% |
| Aqr Capital Management LLC | 621,625 | 0.92% | $6.16M | +326,837 | 0.00% |
| Sb Investment Advisers (Uk) Ltd | 610,729 | 0.91% | $6.05M | – | 0.08% |
| Goldman Sachs Group Inc | 607,376 | 0.90% | $6.02M | −322,486 | 0.00% |
| Bank Of America Corp /De/ | 545,852 | 0.81% | $5.41M | +68,939 | 0.00% |
| Prescott Group Capital Management, L.L.C. | 541,845 | 0.80% | $5.37M | – | 0.46% |
| Renaissance Technologies LLC | 539,856 | 0.80% | $5.35M | +439,400 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 183 | 36M | 53.7% | 30 / 69 | 39 / 19 | 6M | 2M |
| Q1 2026 | 175 | 32M | 48.0% | 30 / 53 | 42 / 31 | 5M | 3M |
| Q4 2025 | 181 | 33M | 48.5% | 35 / 50 | 42 / 27 | 5M | 3M |
| Q3 2025 | 174 | 30M | 45.2% | 31 / 47 | 38 / 21 | 3M | 5M |
| Q2 2025 | 166 | 33M | 49.6% | 35 / 46 | 34 / 34 | 7M | 6M |
| Q1 2025 | 166 | 32M | 47.9% | 31 / 49 | 31 / 28 | 6M | 6M |
| Q4 2024 | 166 | 33M | 48.3% | 41 / 42 | 37 / 24 | 10M | 4M |
| Q3 2024 | 151 | 26M | 39.1% | 150 / 0 | 0 / 1 | 26M | 0M |
| Q2 2024 | 2 | 0M | 0.0% | 2 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
131 funds held DNA in Q2 2026, 66% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of DNA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,489,851 | 2.21% | $14.76M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,251,673 | 1.86% | $12.40M | 0.01% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 550,071 | 0.82% | $5.45M | 0.01% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 523,147 | 0.78% | $4.23M | 0.01% | Jul 31, 2026 |
| PIMCO RAE US Small Fund | 506,312 | 0.75% | $5.02M | 0.13% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 446,538 | 0.66% | $4.43M | 0.03% | Jun 30, 2026 |
| iShares Biotechnology ETF | 356,231 | 0.53% | $3.53M | 0.04% | Jun 30, 2026 |
| ROBO Global Artificial Intelligence ETF | 355,179 | 0.53% | $2.87M | 0.69% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF | 326,836 | 0.49% | $3.24M | 0.11% | Jun 30, 2026 |
| Vanguard Explorer Fund | 251,437 | 0.37% | $2.03M | 0.01% | Jul 31, 2026 |
| Vanguard Strategic Small-Cap Equity Fund | 234,539 | 0.35% | $2.32M | 0.07% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 226,138 | 0.34% | $2.12M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 218,224 | 0.32% | $2.04M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 210,534 | 0.31% | $1.97M | 0.01% | May 31, 2026 |
| Invesco RAFI US 1500 Small-Mid ETF | 187,314 | 0.28% | $1.52M | 0.05% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Reshma P. Shetty | See remarks, Director, 10% owner | 164,705,104 | 244.59% | Oct 21, 2026 |
| Jason R. Kelly | See remarks, Director | 129,065 | 0.19% | Oct 21, 2026 |
| Steven P. Coen | See remarks | 50,168 | 0.07% | Oct 21, 2026 |
| Mark E. Dmytruk | See remarks | 52,132 | 0.08% | May 22, 2025 |
| Christian O. Henry | Director | 19,310 | 0.03% | Sep 16, 2026 |
| Sri Kosuri | Director | 24,067 | 0.04% | Jun 15, 2026 |
| Harry Sloan | Director | 271,418 | 0.40% | Jun 15, 2026 |
| Ross Fubini | Director | 10,822 | 0.02% | Jun 15, 2026 |
| Kathy Hopinkah Hannan | Director | 15,003 | 0.02% | Jun 13, 2025 |
| Shyam Sankar | Director | 72,372 | 0.11% | Jun 13, 2025 |
| Myrtle S. Potter | Director | 10,822 | 0.02% | Jun 13, 2025 |
| Barry Canton | 10% owner | 164,705,104 | 244.59% | Oct 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Steven P. Coen See remarks | Oct 19, 2026 | Sale | −766 | $10.14 | $7.77K | 50,168 |
| Barry Canton 10% owner | Oct 19, 2026 | Sale | −22,369 | $10.14 | $226.89K | 453,951 |
| Barry Canton 10% owner | Oct 19, 2026 | Sale | −18,803 | $10.14 | $190.72K | 356,329 |
| Reshma P. Shetty See remarks, Director, 10% owner | Oct 19, 2026 | Sale | −18,803 | $10.14 | $190.72K | 356,329 |
| Reshma P. Shetty See remarks, Director, 10% owner | Oct 19, 2026 | Sale | −22,369 | $10.14 | $226.89K | 453,951 |
| Jason R. Kelly See remarks, Director | Oct 19, 2026 | Sale | −45,682 | $10.14 | $463.35K | 129,065 |
| Steven P. Coen See remarks | Oct 16, 2026 | Option exercise | +312 | – | – | 50,934 |
| Steven P. Coen See remarks | Oct 16, 2026 | Option exercise | +1,174 | – | – | 50,622 |
| Barry Canton 10% owner | Oct 16, 2026 | Option exercise | +10,619 | – | – | 476,320 |
| Barry Canton 10% owner | Oct 16, 2026 | Option exercise | +29,279 | – | – | 465,701 |
| Barry Canton 10% owner | Oct 16, 2026 | Option exercise | +9,762 | – | – | 375,132 |
| Barry Canton 10% owner | Oct 16, 2026 | Option exercise | +26,802 | – | – | 365,370 |
| Reshma P. Shetty See remarks, Director, 10% owner | Oct 16, 2026 | Option exercise | +9,762 | – | – | 375,132 |
| Reshma P. Shetty See remarks, Director, 10% owner | Oct 16, 2026 | Option exercise | +26,802 | – | – | 365,370 |
| Reshma P. Shetty See remarks, Director, 10% owner | Oct 16, 2026 | Option exercise | +10,619 | – | – | 476,320 |
| Reshma P. Shetty See remarks, Director, 10% owner | Oct 16, 2026 | Option exercise | +29,279 | – | – | 465,701 |
| Jason R. Kelly See remarks, Director | Oct 16, 2026 | Option exercise | +25,790 | – | – | 174,747 |
| Jason R. Kelly See remarks, Director | Oct 16, 2026 | Option exercise | +55,694 | – | – | 148,957 |
| Steven P. Coen See remarks | Oct 5, 2026 | Sale(10b5-1 plan) | −2,403 | $15.00 | $36.05K | 49,448 |
| Christian O. Henry Director | Sep 15, 2026 | Sale | −5,000 | $7.08 | $35.40K | 19,310 |
| Steven P. Coen See remarks | Aug 24, 2026 | Sale | −330 | $6.98 | $2.30K | 51,851 |
| Steven P. Coen See remarks | Aug 21, 2026 | Option exercise | +156 | – | – | 52,181 |
| Steven P. Coen See remarks | Aug 21, 2026 | Option exercise | +587 | – | – | 52,025 |
| Steven P. Coen See remarks | Jul 17, 2026 | Sale | −752 | $7.90 | $5.94K | 51,438 |
| Steven P. Coen See remarks | Jul 16, 2026 | Option exercise | +1,174 | – | – | 51,878 |
| Steven P. Coen See remarks | Jul 16, 2026 | Option exercise | +312 | – | – | 52,190 |
| Steven P. Coen See remarks | May 22, 2026 | Sale | −307 | $8.33 | $2.56K | 50,704 |
| Steven P. Coen See remarks | May 21, 2026 | Option exercise | +587 | – | – | 50,855 |
| Steven P. Coen See remarks | May 21, 2026 | Option exercise | +156 | – | – | 51,011 |
| Steven P. Coen See remarks | Apr 17, 2026 | Sale | −324 | $7.95 | $2.58K | 50,268 |
| Steven P. Coen See remarks | Apr 16, 2026 | Option exercise | +156 | – | – | 50,592 |
| Steven P. Coen See remarks | Apr 16, 2026 | Option exercise | +587 | – | – | 50,436 |
| Steven P. Coen See remarks | Apr 13, 2026 | Sale | −33,171 | $6.41 | $212.63K | 49,849 |
| Steven P. Coen See remarks | Apr 10, 2026 | Option exercise | +28,368 | – | – | 37,467 |
| Steven P. Coen See remarks | Apr 10, 2026 | Option exercise | +45,553 | – | – | 83,020 |
| Reshma P. Shetty See remarks, Director, 10% owner | Apr 10, 2026 | Sale | −124,727 | $6.43 | $801.99K | 436,422 |
| Barry Canton 10% owner | Apr 10, 2026 | Sale | −124,727 | $6.43 | $801.99K | 436,422 |
| Reshma P. Shetty See remarks, Director, 10% owner | Apr 9, 2026 | Option exercise | +251,786 | – | – | 561,149 |
| Barry Canton 10% owner | Apr 9, 2026 | Option exercise | +251,786 | – | – | 561,149 |
| Jason R. Kelly See remarks, Director | Apr 9, 2026 | Sale | −109,767 | $6.40 | $702.51K | 316,483 |
| Reshma P. Shetty See remarks, Director, 10% owner | Apr 9, 2026 | Sale | −13,116 | $6.40 | $83.94K | 338,568 |
| Barry Canton 10% owner | Apr 9, 2026 | Sale | −13,116 | $6.40 | $83.94K | 338,568 |
| Jason R. Kelly See remarks, Director | Apr 8, 2026 | Sale | −97,015 | $6.93 | $672.31K | 426,250 |
| Jason R. Kelly See remarks, Director | Apr 8, 2026 | Option exercise | +212,949 | – | – | 523,265 |
| Reshma P. Shetty See remarks, Director, 10% owner | Apr 8, 2026 | Sale | −13,155 | $6.93 | $91.16K | 351,684 |
| Reshma P. Shetty See remarks, Director, 10% owner | Apr 8, 2026 | Option exercise | +27,738 | – | – | 364,839 |
| Barry Canton 10% owner | Apr 8, 2026 | Option exercise | +27,738 | – | – | 364,839 |
| Barry Canton 10% owner | Apr 8, 2026 | Sale | −13,155 | $6.93 | $91.16K | 351,684 |
| Jason R. Kelly See remarks, Director | Apr 7, 2026 | Option exercise | +212,949 | – | – | 310,316 |
| Reshma P. Shetty See remarks, Director, 10% owner | Apr 7, 2026 | Option exercise | +27,738 | – | – | 337,101 |
| Barry Canton 10% owner | Apr 7, 2026 | Option exercise | +27,738 | – | – | 337,101 |
| Steven P. Coen See remarks | Mar 16, 2026 | Sale | −708 | $6.74 | $4.77K | 9,099 |
| Steven P. Coen See remarks | Mar 13, 2026 | Option exercise | +312 | – | – | 9,807 |
| Steven P. Coen See remarks | Mar 13, 2026 | Option exercise | +1,174 | – | – | 9,495 |
| Steven P. Coen See remarks | Jan 20, 2026 | Sale | −972 | $8.92 | $8.67K | 8,321 |
| Steven P. Coen See remarks | Jan 16, 2026 | Option exercise | +1,062 | – | – | 9,293 |
| Steven P. Coen See remarks | Jan 16, 2026 | Option exercise | +587 | – | – | 8,075 |
| Steven P. Coen See remarks | Jan 16, 2026 | Option exercise | +156 | – | – | 8,231 |
| Steven P. Coen See remarks | Dec 15, 2025 | Sale | −736 | $8.89 | $6.54K | 7,488 |
| Steven P. Coen See remarks | Dec 12, 2025 | Option exercise | +1,174 | – | – | 7,912 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ginkgo Bioworks's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,216 shares on Oct 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jason R. Kelly Officer, Director | Oct 19, 2026 | 45,682 | $463.33K | Oct 19, 2026 | Restricted Stock Vesting |
| Steven P. Coen Officer | Oct 19, 2026 | 766 | $7.77K | Oct 19, 2026 | Restricted Stock Vesting |
| Barry Canton Officer | Oct 19, 2026 | 18,803 | $190.71K | Oct 19, 2026 | Restricted Stock Vesting |
| Che Austin Officer | Oct 19, 2026 | 16,058 | $162.87K | Oct 19, 2026 | Restricted Stock Vesting |
| Reshma P. Shetty Officer, Director | Oct 19, 2026 | 22,369 | $226.88K | Oct 19, 2026 | Restricted Stock Vesting |
| Che Austin Officer | Oct 19, 2026 | 2,200 | $22.84K | Oct 19, 2026 | Restricted Stock Vesting |
| Steven P. Coen Officer | Oct 5, 2026 | 2,403 | $36.05K | Oct 5, 2026 | Restricted Stock Vesting |
| Che Austin Officer | Sep 17, 2026 | 2,200 | $16.04K | Sep 17, 2026 | Restricted Stock Vesting |
| Christian O. Henry Director | Sep 15, 2026 | 5,000 | $35.41K | Sep 15, 2026 | Restricted Stock Vesting |
| Steven P. Coen Officer | Aug 24, 2026 | 330 | $2.30K | Aug 24, 2026 | Restricted Stock Vesting |
| Che Austin Officer | Aug 17, 2026 | 2,200 | $14.65K | Aug 17, 2026 | Restricted Stock Vesting |
| Steven P. Coen Officer | Jul 17, 2026 | 752 | $5.94K | Jul 17, 2026 | Restricted Stock Vesting |
| Che Austin Officer | Jun 10, 2026 | 2,200 | $17.73K | Jun 10, 2026 | Restricted Stock Vesting |
| Steven P. Coen Officer | May 22, 2026 | 307 | $2.56K | May 22, 2026 | Restricted Stock Vesting |
| Che Austin Officer | May 13, 2026 | 2,200 | $18.22K | May 13, 2026 | Restricted Stock Vesting |
See a number that looks wrong?